These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
4. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. Yi CA; Lee KS; Kim BT; Choi JY; Kwon OJ; Kim H; Shim YM; Chung MJ J Nucl Med; 2006 Mar; 47(3):443-50. PubMed ID: 16513614 [TBL] [Abstract][Full Text] [Related]
5. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography. Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
7. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT. Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020 [TBL] [Abstract][Full Text] [Related]
9. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586 [TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL; Kuester LB; Muse VV; Halpern EF; Fischman AJ Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):692-6. PubMed ID: 16514531 [TBL] [Abstract][Full Text] [Related]
12. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules. Li W; Pang H; Liu Q; Zhou J Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866 [TBL] [Abstract][Full Text] [Related]
13. [Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules]. Tian R; Su MG; Tian Y; Li FL; Kuang AR Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):404-8. PubMed ID: 22812247 [TBL] [Abstract][Full Text] [Related]
14. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT. Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128 [TBL] [Abstract][Full Text] [Related]
15. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]
16. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule]. Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792 [TBL] [Abstract][Full Text] [Related]
17. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules? Lohrmann C; Weber WA Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239 [TBL] [Abstract][Full Text] [Related]
19. The value of ¹⁸F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis. Li Y; Su M; Li F; Kuang A; Tian R Ann Nucl Med; 2011 Dec; 25(10):804-11. PubMed ID: 21879296 [TBL] [Abstract][Full Text] [Related]
20. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology. Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]